- Auris Medical Holding AG EARS dropped 59.6 percent to $2.16 as the company issued results from TACTT2 trial with Keyzilen in acute inner ear tinnitus. The trial did not meet co-primary efficacy endpoints. The company also reported Q2 earnings of CHF0.25 per share.
- Cerulean Pharma Inc CERU shares tumbled 55.1 percent to $1.23 after the company reported failed CRLX101/Avastin trial results. Leerink Swann, Janney Capital and JMP Securities downgraded the stock following the news.
- The GEO Group Inc GEO shares declined 39.3 percent to $19.59. The Department of Justice announced that it would be phasing out the use of private prisons. The topic has been a controversial one for sometime, and the U.S. government finally determined that these private correctional facilities were not run as effectively and safe as government-run prisons.
- Corrections Corp Of America CXW fell 38.8 percent to $16.60 as the Department of Justice announced that it would be phasing out the use of private prisons.
- Juniper Pharmaceuticals Inc JNP shares dipped 24.1 percent to $5.40. Juniper Pharma reported that its Phase 2b trial of COL-1077 lidocaine vaginal gel did not meet primary and secondary endpoints.
- Portola Pharmaceuticals Inc PTLA shares declined 15.5 percent to $20.02 as the company reported that it has received a CRL from the FDA for Biologics License Application for AndexXa.
- Oncomed Pharmaceuticals Inc OMED shares dropped 14.4 percent to $10.02. OncoMed priced an offering of 5.5 million shares at $10 per share.
- Briggs & Stratton Corporation BGG declined 13.4 percent to $19.02 as the company posted weak Q4 results.
- 58.com Inc (ADR) WUBA fell 13.2 percent to $46.49 after the company reported Q2 results and issued a disappointing Q3 guidance.
- Accuray Incorporated ARAY dropped 13 percent to $5.01 as the company posted a wider-than-expected quarterly loss.
- Communications Systems, Inc. JCS fell 8.2 percent to $6.30. Communications Systems has declared a quarterly dividend of $0.04 per share and increased its line of credit from $10 million to $15 million.
- Twitter Inc TWTR shares dropped 5.7 percent to $19.02. Evercore ISI Group downgraded Twitter from Hold to Sell and lowered the price target from $18.00 to $17.00.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
